![]() |
市場調查報告書
商品編碼
1955091
全球驗光儀市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Phoropters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球驗光儀市場在眼科診斷中發揮著至關重要的作用,能夠精確測量近視、遠視、散光和老花眼等屈光不正。 驗光儀被眼科醫生和驗光師廣泛用於日常眼科檢查,以確定準確的視力矯正處方。
市場規模及預測
根據 Fortune Business Insights 的數據,2025 年全球驗光儀市場規模為 1.6075 億美元。 預計到 2026 年市場規模將成長至 1.6786 億美元,並在 2034 年進一步達到 2.3379 億美元,在預測期(2026-2034 年)內複合年增長率 (CAGR) 為 4.23%。
這一穩定成長得益於人們對眼部健康的日益重視、屈光不正盛行率的上升以及全球眼科醫療基礎設施的擴展。
市場概覽
驗光儀是一種眼科設備,由鏡片、棱鏡和柱鏡組成,用於透過測量光線在視網膜上的聚焦情況來評估屈光不正。眼科醫療專業人員將驗光儀作為視力測試的標準診斷工具。
生活方式的改變、長時間接觸電子螢幕以及人口老化顯著增加了人們對定期眼科檢查的需求。 近期發布的臨床指南,例如美國驗光協會 (AOA) 2023 年建議 18 至 64 歲人群每年進行眼科檢查,進一步推動了市場擴張。 主要市場驅動因素 主要成長驅動因素之一是全球屈光不正盛行率的上升。本報告引用的研究表明,兒童和成人近視和遠視病例均增加。此外,糖尿病等慢性疾病(高血糖會導致屈光改變)也擴大了需要定期進行眼科檢查的患者族群。 另一個重要因素是,由於醫療保健支出增加以及政府為加強眼科醫療服務而採取的舉措,驗光師和眼科醫生的數量也在不斷增長。人口老化,尤其是在已開發市場,也推動了對眼科診斷設備(包括驗光儀)的需求。 市場趨勢 影響驗光儀市場的一個關鍵趨勢是,人們越來越傾向於選擇自動驗光儀而非手動驗光儀。自動驗光儀具有許多優勢,例如縮短檢查時間、提高準確性、與電子病歷無縫整合以及減輕臨床醫生的體力負擔。
先進的數位系統,例如配備觸控螢幕介面和預設檢查功能的自動驗光儀,正日益被應用於先進的醫療環境中,從而鞏固了自動化設備在市場上的主導地位。
限制因子
儘管需求強勁,但自動驗光儀的高昂成本仍然是一個主要的限制因素,尤其是在新興經濟體。自動化系統的成本,包括安裝和維護費用,限制了小型診所和預算有限的醫療機構採用這些系統。這種價格敏感性持續阻礙中低收入地區的市場滲透。
依產品類型劃分,驗光儀分為手動型和自動型。自動型驗光儀憑藉其在效率、準確性和節省時間方面的優勢,佔了最大的市場佔有率並主導著市場。 由於價格低廉,手動驗光儀仍在小型診所中使用。
依最終用戶劃分,眼科診所佔了大部分市場佔有率。這主要歸功於個別診所的增加以及對門診眼科的日益重視。由於屈光不正和眼部疾病負擔的加重,醫院也對市場做出了顯著貢獻。
北美將在2025年以41.85%的市佔率引領全球驗光儀市場。這得益於該地區數位眼部疲勞的高發生率、完善的醫保報銷體係以及成熟的眼科醫療專業人員網絡。美國仍然是該地區最大的貢獻者。
歐洲將佔第二大市場佔有率,這得益於監管意識提升計劃和早期眼科檢查倡議。亞太地區正經歷顯著成長,這得益於醫療保健投資的增加、國內製造商競爭力的增強以及日本、中國、印度和其他國家對先進眼科技術的日益普及。
The global phoropter market plays a critical role in ophthalmic diagnostics, enabling accurate measurement of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia. Phoropters are widely used by optometrists and ophthalmologists during routine eye examinations to determine precise vision prescriptions.
Market Size & Forecast
According to Fortune Business Insights, the global phoropter market was valued at USD 160.75 million in 2025. The market is projected to grow to USD 167.86 million in 2026 and further reach USD 233.79 million by 2034, registering a CAGR of 4.23% during the forecast period (2026-2034).
This steady growth is supported by rising awareness of eye health, increasing prevalence of refractive disorders, and the expansion of ophthalmic care infrastructure globally.
Market Overview
A phoropter is an ophthalmic device comprising lenses, prisms, and cylinders used to evaluate refractive errors by determining how light focuses on the retina. Eye care professionals rely on phoropters as a standard diagnostic tool during vision testing.
The demand for routine eye examinations has increased significantly due to lifestyle changes, prolonged digital screen exposure, and a growing elderly population. Updated clinical guidelines, such as the American Optometric Association's 2023 recommendation for annual eye exams for individuals aged 18-64, further support market expansion.
Key Market Drivers
One of the primary growth drivers is the rising prevalence of refractive errors worldwide. Studies cited in the report indicate increasing cases of myopia and hyperopia across both pediatric and adult populations. Additionally, chronic conditions such as diabetes mellitus, which are linked to refractive changes due to hyperglycemia, are expanding the patient pool requiring regular eye examinations.
Another significant factor is the increasing number of optometrists and ophthalmologists, driven by higher healthcare expenditure and government initiatives to strengthen eye care services. The aging population, particularly in developed markets, is also increasing demand for ophthalmic diagnostics, including phoropters.
Market Trends
A major trend shaping the phoropter market is the growing preference for automated phoropters over manual systems. Automated phoropters offer faster testing, higher accuracy, seamless integration with electronic medical records, and reduced physical workload for clinicians.
Advanced digital systems, such as automated refraction units with touchscreen interfaces and pre-programmed tests, are increasingly adopted in developed healthcare settings, supporting the dominance of automated devices in the market.
Restraining Factors
Despite strong demand, high costs associated with automated phoropters remain a key restraint, especially in emerging economies. The cost of automated systems, including installation and maintenance, limits adoption among small clinics and budget-constrained healthcare facilities. This price sensitivity continues to restrict market penetration in low- and middle-income regions.
By Product Type, the market is segmented into manual and automated phoropters. The automated segment dominated the market, accounting for the largest share due to efficiency, accuracy, and time-saving benefits. Manual phoropters continue to be used in smaller clinics due to their lower cost.
By End User, ophthalmic clinics held the dominant market share, supported by the rising number of private practices and increasing focus on outpatient eye care. Hospitals also contribute significantly due to the growing burden of refractive and ocular disorders.
North America dominated the global phoropter market with a 41.85% share in 2025, driven by high prevalence of digital eye strain, strong reimbursement frameworks, and a well-established network of eye care professionals. The U.S. remains the largest contributor in the region.
Europe held the second-largest share, supported by regulatory awareness programs and early eye examination initiatives. Asia Pacific is witnessing notable growth due to rising healthcare investment, strong domestic manufacturers, and increasing adoption of advanced ophthalmic technologies in countries such as Japan, China, and India.
Competitive Landscape
The market is partially fragmented, with key players including Reichert, Inc. (AMETEK, Inc.), NIDEK CO., LTD., ZEISS, EssilorLuxottica, Topcon Corporation, Visionix, and Rexxam Co., Ltd. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Conclusion
The global phoropter market demonstrates stable and sustained growth from 2025 to 2034, increasing from USD 160.75 million in 2025 to USD 233.79 million by 2034. Growth is driven by rising refractive error prevalence, increasing demand for routine eye examinations, technological advancements in automated phoropters, and expansion of ophthalmic clinics. While high equipment costs limit adoption in emerging regions, continued innovation and healthcare investments are expected to support long-term market expansion.
Segmentation By Product Type
By End User
By Region